The panel voted on just one question: Based on the totality of scientific evidence available, do the benefits of the Johnson & Johnson COVID-19 vaccine outweigh its risks for use in individuals 18 years of age and older?
All members of the committee voted “yes” to recommend the FDA grant emergency use authorization for the vaccine.
The FDA is expected to follow the committee’s recommendation and issue an emergency use authorization for the vaccine as soon as Feb. 27, according to The New York Times.
The vaccine committee, called the Vaccines and Related Biological Products Advisory Committee, is made up of outside experts, including physicians, academics, disease experts and biostatisticians. They have all been vetted for conflicts of interest before becoming members of the committee.
More articles on pharmacy:
Moderna, Pfizer testing ways to boost COVID-19 vaccines against variants
Kentucky compounding pharmacy forfeits $1.8M for illegal drug distribution scheme
Moderna CMO to leave the company
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
